Organization
University of Aberdeen
1 clinical trial
3 abstracts
Clinical trial
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy: The GENETIC StudyStatus: Recruiting, Estimated PCD: 2028-12-31
Abstract
A NOVEL SMALL MOLECULE, MBS2133, MODULATES OSTEOCLAST PRE-CURSOR METABOLISM TO INHIBIT OSTEOCLAST DIFFERENTIATION: AN ALTERNATIVE THERAPY FOR OSTEOLYTIC PATHOLOGY IN RAOrg: Istesso Ltd, London, United Kingdom, Johnson and Johnson Innovation, London, United Kingdom, University of Glasgow, University of Liverpool, University of Aberdeen,
Abstract
A PHASE 2A TRIAL TO EVALUATE CRX-102 FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITISOrg: Combinatorx Incorporated, University of Bristol - Bristol Medical School, Bristol, United Kingdom, East Tallinn Central Hospital, Weston Area Health Trust, University of Aberdeen,
Abstract
A SINGLE INFUSION OF ZOLEDRONIC ACID 5 MG IS SIGNIFICANTLY MORE EFFECTIVE THAN DAILY ORAL RISEDRONATE 5 MG IN INCREASING BONE MINERAL DENSITY OF THE LUMBAR SPINE, HIP, FEMORAL NECK AND TROCHANTER IN PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSISOrg: University of Aberdeen, Unité de Rhumatolgie, University of Alabama at Birmingham Department of Hematology, Birmingham, AL, Paris-Descartes University, Paris, France, University of Dundee,